N-(2-bromo-4-methylphenyl)-1-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]piperidine-3-carboxamide
C20H25BrN4O2S — CID 84564176
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-bromo-4-methylphenyl)-1-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]piperidine-3-carboxamide
N-(2-bromo-4-methylphenyl)-1-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]piperidine-3-carboxamide (PubChem CID 84564176) has the molecular formula C20H25BrN4O2S and a molecular weight of 465.42 g/mol. Its IUPAC name is N-(2-bromo-4-methylphenyl)-1-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]piperidine-3-carboxamide.
Molecular Properties
| Compound Name | N-(2-bromo-4-methylphenyl)-1-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]piperidine-3-carboxamide |
|---|---|
| PubChem CID | 84564176 |
| Molecular Formula | C20H25BrN4O2S |
| Molecular Weight | 465.42 g/mol |
| Exact Mass | 464.09 |
| IUPAC Name | N-(2-bromo-4-methylphenyl)-1-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]piperidine-3-carboxamide |
| SMILES | Cc1ccc(NC(=O)C2CCCN(CC(=O)Nc3nc(C)c(C)s3)C2)c(Br)c1 |
| InChI | InChI=1S/C20H25BrN4O2S/c1-12-6-7-17(16(21)9-12)23-19(27)15-5-4-8-25(10-15)11-18(26)24-20-22-13(2)14(3)28-20/h6-7,9,15H,4-5,8,10-11H2,1-3H3,(H,23,27)(H,22,24,26) |
| InChIKey | SOELQQLBFXGZNN-UHFFFAOYSA-N |
| XLogP | 4.12 |
| TPSA | 74.33 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.42 |
| LogP ≤ 5 | 4.12 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 84564176 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.